H-ciPTECs increased collagen IV deposition when co-treated with TGF-β, while this was not observed in the sham, vehicle and ischemic groups, confirming the efficacy of our model to mimic the progression to chronic kidney disease observed after AKI (Additional file 1: Fig. S1). This evidence concerns the gene TGFB1 and chronic kidney disease.